V
Viridos
Aviation · San Diego, United States · Founded 2005
A leader in the field of synthetic biology, advancing genomics to better life MoreLess
Viridos is a biotechnology startup that is focused on developing advanced biofuel technology to mitigate climate change. The company's primary product is algal biofuel, a renewable energy source that offers a solution for industries struggling to decarbonize. Viridos operates in the renewable energy market, specifically in the biofuel sector, serving clients across various industries that are seeking sustainable energy alternatives.
The company's business model revolves around the development and commercialization of its proprietary algal biofuel technology. It generates revenue by selling this biofuel to industries that are transitioning away from fossil fuels. Viridos has also formed a strategic partnership with ExxonMobil, a major player in the energy sector, to bring algae biofuel to the global stage. This partnership is aimed at decarbonizing heavy transportation, a sector that has traditionally been reliant on fossil fuels.
In addition to its biofuel technology, Viridos has developed a proprietary RNA replicon platform for creating innovative vaccines and therapeutics. This platform uses advanced genomics and bioengineering to selectively stimulate the immune system and deliver targeted therapies produced within the body.
The company's mission is to replace unsustainable systems with products and processes that reduce greenhouse gas emissions, ultimately contributing to a future where everyone can thrive. Every position at Viridos supports this higher purpose of mitigating climate change.
Keywords: Biotechnology, Biofuel, Algae, Renewable Energy, Climate Change Mitigation, Decarbonization, Heavy Transportation, ExxonMobil Partnership, RNA Replicon Platform, Sustainable Systems.
Company overview
Viridos company information
The essential company record, classifications and operating signals in one place.
- Status
- Operational
- Founded
- 2005
- Headquarters
- San Diego, United States
- Employees
- 47
- Open positions
- None listed
- Dealroom signal
- 64.5
- Investment activity
- 1 companies · latest Jan 2013
- Capital deployed
- $0
- Preferred round
- CORPORATE SPINOUT
Valuation & funding
Viridos funding history
Company financing events and reported valuations.
| Deal type | Date | Amount | Valuation | Investors | Source |
|---|---|---|---|---|---|
| SERIES AOther financing | Mar 2023 | $25M | $250M | Breakthrough Energy Ventures · United Airlines Venture · Chevron | ↗ |
| GRANTOther financing | Apr 2022 | $0 | — | Undisclosed | ↗ |
| EARLY VCOther financing | Apr 2014 | $50M | $200M | Lung Biotechnology | — |
| EARLY VCOther financing | Feb 2013 | $0 | — | OS Fund | — |
| EARLY VCOther financing | Oct 2011 | $0 | — | BP Ventures | — |
| EARLY VCOther financing | Jun 2010 | LifeTechnologies | — | ||
| EARLY VCOther financing | Jun 2007 | BP Ventures | — | ||
| SERIES AOther financing | Dec 2005 | Frontier Venture Capital · Biotechonomy | — |
Growth signals
Viridos website traffic
Latest recorded traffic for Viridos is 1.6K monthly website visits, up 344.4% over the last three months. Viridos's team declined 6% over the past year.
Comparisons
Viridos compared with similar companies
Dealroom’s weighted taxonomy model identifies the closest operating peers. Company identity and context stay open; selected comparison metrics preview what is available in the platform.
Capital deployed
Viridos investments and acquisitions
Recent portfolio relationships for companies that also act as investors or acquirers.
Talent graph
Viridos's talent
Source: Dealroom Talent Intelligence.
Investors
9 investors on Viridos's cap table
Sourced from Dealroom's funding and investor records.







Global footprint
Where Viridos has talent and traffic
team presence
In the news
Latest news about Viridos
Recent press, funding announcements, and product moves mentioning Viridos — open to read from the original sources.
Market sentiment
What the market is saying about Viridos
An AI-synthesized read of the highest-engagement posts about Viridos on X over the past 7 days. We rank by likes & retweets, ignore corporate channels, and surface the themes that broke out from real people.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Viridos’s full profile on Dealroom
Request a free trial to see the complete deal history, financials, people graph and growth signals.
Takes under a minute. Already use Dealroom? Log in.








